Case Study

EHR Banner Ads Help HCPs Find Brand-Eligible Oncology Patients

Client

Oncology Brand

Key Results

Boosts Patient Starts by 28%

The challenge

Challenge

A top 20 biopharmaceutical company faced a challenge with an oncology brand that offered strong clinical benefits but had a narrow treatment initiation window due to step therapy requirements. Many healthcare providers (HCPs) became aware of the therapy too late—after patients were no longer eligible. With no clear test or trigger to signal patient qualification, the brand struggled to drive timely patient starts.

OptimizeRx AI-powered solution accelerated the brand's oncology therapy initiation.

The solution

Predictive AI Model Development

Built a proprietary AI algorithm using multiple longitudinal real-world datasets. Designed to detect when patients were likely to change lines of therapy—indicating they were nearing eligibility for the oncology brand. Enabled identification of brand-qualified patients even in the absence of a clear diagnostic trigger.

Timely HCP Engagement

Delivered AI-driven alerts within the EHR workflow, prompting oncologists just before patients became eligible. Ensured brand consideration during critical treatment decision points, improving timing and relevance of communication

Efficient Targeting and Deployment

Focused communications only on oncologists treating potentially eligible patients. Allowed for smarter deployment of brand messaging and more effective use of field team resources. Helped prioritize HCP outreach, increasing the impact of both digital and in-person engagement efforts.

EHR Integration

Embedded the program within providers' existing clinical workflows. Raised awareness of patient eligibility in real time—where and when treatment decisions were made.

The results

Results

OptimizeRx's AI-Powered Solution Accelerates Oncology Therapy Initiation Program Duration: 12 months.

Impact: The AI-driven, EHR-integrated strategy ensured timely brand consideration, optimized HCP outreach, and significantly boosted patient access to the oncology therapy.

Key results

Increase in Patient Starts: Accelerated therapy initiation through proactive patient identification.

28%

of New Patients from Targeted HCPs: Enhanced engagement with oncologists at critical decision points.

33%

ROI: Demonstrated efficient use of resources and high campaign impact.

3.8:1

Results that speak for themselves.

From rare disease to mass markets, our clients move faster, waste less, and turn coordinated marketing into measurable script lift.

Data Driven Decision-Making Drove 10:1 Return on TV Ad Spend

Learn how data-driven decision making in pharma delivered a 10:1 ROI on TV ad spend through precise targeting and omnichannel engagement.

The ad ranked in the top 25% for impressions per new prescriptions (NRx) generated.

25%

Return on Advertising Spend (ROAS) Digital Display

10:1

Audience segments ranked in the top one-third for impressions per NRx generated.

3/4

AI-Powered EHR Messaging Drives Significant Referrals for Rare Disease Treatment Referral

Discover how AI in HCP engagement improved rare disease referrals by delivering timely, EHR-based education to pediatricians and specialists.

Higher Overall Referral Rate in the test group compared to the control group.

23x

Increase in Pediatric Endocrinology Referrals in the test group versus the control group.

110x

Increase in Pediatric Genetics Referrals in the test group

~6x

Improving Audience Quality for CTV with Clinical Connected Datasets

See how OptimizeRx drove ROI in pharma CTV advertising by using clinical data and Micro-Neighborhood® targeting to improve audience quality.

OptimizeRx targeting had the best performance of all partners in both audience quality and cost per diagnosed patient

Our Micro-Neighborhood® targeting platform produced higher audience quality than the national benchmark

Higher audience quality rate than the next performing partner

60%

Healthcare marketing is evolving.

Ready for more than just a data vendor?